Clinical Trials Browser

Phase 2 × INDUSTRY × Inflammatory Breast Neoplasms × Clear all

NCT03184558 2021-11-09

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC

Phase 2 Terminated

29 enrolled 10 charts

Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00105950 2015-09-28

Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer

Phase 2 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00558103 2013-02-04

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer

Phase 2 Completed

163 enrolled 14 charts

Breast Neoplasms, Inflammatory Breast Neoplasms